Poor prognosis [fndg]    
ovarian cancer [neop]    
Marker [clna]    
Cancer Stem Cells [cell]    
Human [humn]    
malignant tumors [neop]    
Including [ftcn]    
ovarian cancer [neop]    
Tumour NOS [neop]    
Initiate [idcn]    
Subpopulation [popg]    
Cells [cell]    
Patients [podg]    
TIME [tmco]    
Clinical Significance [fndg]    
ovarian cancer [neop]    
Uncertain [fndg]    
Study [mnob]    
Clarify [acty]    
Human [humn]    
ovarian cancer [neop]    
Immunohistochemical [lbpr]    
Staining [lbpr]    
Performed [ftcn]    
OVARIAN CARCINOMA [neop]    
Sample [sbst]    
Tissue Microarray [resd]    
Associations [menp]    
DIAGNOSIS [fndg]    
Tumour NOS [neop]    
Grade [clas]    
cancer stage [diap]    
Clinical Response [fndg]    
Chemotherapy [topp]    
Survival [acty]    
Disease-Free Survival [qnco]    
TIME [tmco]    
OVARIAN CARCINOMA [neop]    
Sample [sbst]    
Variance [qlco]    
Suggest [idcn]    
High grade serous carcinoma [neop]    
Late stage [tmco]    
ASCITES [fndg]    
0.010" [qnco]    
Response [orga]    
Chemotherapy [topp]    
short [qlco]    
Survival time [clna]    
short [qlco]    
Disease-Free Survival [qnco]    
TIME [tmco]    
Log [inpr]    
Rank [inpr]    
Test [lbpr]    
Independent [idcn]    
short [qlco]    
Disease-Free Survival [qnco]    
TIME [tmco]    
Unconditional [qlco]    
logistic regression analysis [resa]    
MULTIPLE [qnco]    
Poor outcome [fndg]    
Patients [podg]    
ovarian cancer [neop]    
Support, NOS [medd]    
Proposed [qlco]    
Link [inpr]    
Cancer Stem Cells [cell]    
Pathology [bmod]    
DOI [clas]    
Published [ocac]    
November [tmco]    
